
    
      This is an 8 week trial with extension for responders out to one year. All patients receive
      active medication; there is no placebo. Patients must meet criteria for the schizophrenia
      prodrome according to the Structured Interview for Prodromal Syndromes. Patients receive
      counseling as well. All counseling and medication are free of charge.
    
  